RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vivozon Pharmaceutical Co Stock

Vivozon Pharmaceutical Co Stocks 2024

Vivozon Pharmaceutical Co Stocks

47.72 M

Ticker

082800.KQ

ISIN

KR7082800004

In 2024, Vivozon Pharmaceutical Co had 47.72 M outstanding stocks, a 9.69% change from the 43.51 M stocks in the previous year.

The Vivozon Pharmaceutical Co Stocks history

YEARNUMBER OF STOCKS (undefined KRW)
202347.72
202243.51
202132.61
2020131
2019105
201856
201738
201638
201538
201438
201335
201236
201136
201034
200920
200813
200712
20069
20056
20046

Vivozon Pharmaceutical Co shares outstanding

The number of shares was Vivozon Pharmaceutical Co in 2023 — This indicates how many shares 47.719 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Vivozon Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Vivozon Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Vivozon Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Vivozon Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Vivozon Pharmaceutical Co Aktienanalyse

What does Vivozon Pharmaceutical Co do?

Vivozon Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Vivozon Pharmaceutical Co's Shares Outstanding

Vivozon Pharmaceutical Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Vivozon Pharmaceutical Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Vivozon Pharmaceutical Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Vivozon Pharmaceutical Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Vivozon Pharmaceutical Co stock

How many stocks are there of Vivozon Pharmaceutical Co?

The current number of stocks of Vivozon Pharmaceutical Co is 47.72 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Vivozon Pharmaceutical Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Vivozon Pharmaceutical Co evolved in recent years?

The number of shares of Vivozon Pharmaceutical Co has increased by 9.69% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Vivozon Pharmaceutical Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Vivozon Pharmaceutical Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Vivozon Pharmaceutical Co pay?

Over the past 12 months, Vivozon Pharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vivozon Pharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Vivozon Pharmaceutical Co?

The current dividend yield of Vivozon Pharmaceutical Co is .

When does Vivozon Pharmaceutical Co pay dividends?

Vivozon Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vivozon Pharmaceutical Co?

Vivozon Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Vivozon Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vivozon Pharmaceutical Co located?

Vivozon Pharmaceutical Co is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Vivozon Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vivozon Pharmaceutical Co from 9/8/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 9/8/2024.

When did Vivozon Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 9/8/2024.

What was the dividend of Vivozon Pharmaceutical Co in the year 2023?

In the year 2023, Vivozon Pharmaceutical Co distributed 0 KRW as dividends.

In which currency does Vivozon Pharmaceutical Co pay out the dividend?

The dividends of Vivozon Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vivozon Pharmaceutical Co

Our stock analysis for Vivozon Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vivozon Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.